Notice2025-10518
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
June 11, 2025
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 111 (Wednesday, June 11, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 111 (Wednesday, June 11, 2025)]
[Notices]
[Pages 24615-24616]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-10518]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-25-1446]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Risk factors, clinical course, presence and
persistence of virus in various bodily fluids, and risk of sexual
transmission among U.S. adults with Oropouche virus disease'' to the
Office of Management and Budget (OMB) for review and approval. CDC
previously published a ``Proposed Data Collection Submitted for Public
Comment and Recommendations'' notice on November 4, 2024 to obtain
comments from the public and affected agencies. CDC did not receive
comments related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Risk factors, clinical course, presence and persistence of virus in
various bodily fluids, and risk of sexual transmission among U.S.
adults with Oropouche virus disease (OMB Control No. 0920-1446, Exp. 3/
31/2025)--Reinstatement--National Center for Emerging and Zoonotic
Diseases (NCEZID), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Data collection for this project was originally approved through an
Emergency Information Collection Request (ICR). CDC is submitting this
package as a Revision to convert it into a standard ICR under the PRA.
CDC will work with state health departments to determine if any
individuals who either are reported as Oropouche virus (OROV) disease
cases to ArboNET, the national surveillance system for arboviral
diseases, or have samples submitted to CDC that test positive for OROV
infection meet the inclusion criteria for the study. The goals of this
study are to assess potential risk factors for OROV disease, describe
the clinical course and outcomes of OROV disease among U.S. travelers,
and to assess the prevalence and duration of OROV, viral RNA, and OROV-
specific neutralizing antibodies in various
[[Page 24616]]
bodily fluids. The results of this investigation will inform prevention
and messaging and aid in clinical diagnosis and care.
CDC requests OMB approval for an estimated 663 annual burden hours.
There are no costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number Avg. burden
Type of respondent Form name Number of responses per per response
respondents respondent (in hrs.)
----------------------------------------------------------------------------------------------------------------
General public........................ Baseline survey......... 200 1 30/60
Follow-up clinical 200 6 15/60
survey.
Symptom Diary........... 200 6 10/60
Contact Tracing Survey.. 100 1 15/60
Sexual Contact Interview 150 1 15/60
form.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2025-10518 Filed 6-10-25; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on June 11, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.